Aucoin M, Lachance L, Cooley K, Kidd S (2020) Diet and psychosis: a scoping review. Neuropsychobiology 79(1):20–42
Article
CAS
PubMed
Google Scholar
Parle M, Kadian R (2013) Behavioral models of psychosis. Int Res J Pharm 4:26–30
Article
Google Scholar
Shao L, Martin MV, Watson SJ, Schatzberg A, Akil H, Myers RM, Jones EG, Bunney WE, Vawter MP (2005) Mitochondrial involvement in psychiatric disorders. Ann Med 40(4):281–295
Article
CAS
Google Scholar
Rajasekaran A, Venkatasubramanian G, Berk M, Debnath M (2015) Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications. Neurosci Biobehav Rev 48:10–21
Article
CAS
PubMed
Google Scholar
Miean KH, Mohamed S (2001) Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J Agric Food Chem 49(6):3106–3112
Article
CAS
PubMed
Google Scholar
Hwang SL, Shih PH, Yen GC (2012) Neuroprotective effects of citrus flavonoids. J Agric Food Chem 160(4):877–885
Article
CAS
Google Scholar
Yadav M, Parle M, Sachdeva M, Dhingra S (2017) Standardisation and validation of acute and chronic administration ketamine at different doses to produce psychosis-like behavioural changes in mice. Int J Toxicol Pharmacol Res 9(1):33–38
Google Scholar
Yadav M, Parle M, Sharma N, Dhingra S, Raina N, Jindal DK (2017) Brain targeted oral delivery of doxycycline hydrochloride encapsulated tween 80 coated chitosan nanoparticles against ketamine-induced psychosis: behavioral, biochemical, neurochemical and histological alterations in mice. Drug Deliv 24(1):1429–1440
Article
CAS
PubMed
PubMed Central
Google Scholar
Rishitha N, Muthuraman A (2018) Therapeutic evaluation of solid lipid nanoparticle of quercetin in pentylenetetrazole induced cognitive impairment of zebrafish. Life Sci 199:80–87
Article
CAS
PubMed
Google Scholar
Hajialyani M, Farzaei MH, Echeverría J, Nabavi SM, Uriarte E, Eduardo SS (2019) Hesperidin as a neuroprotective agent: a review of animal and clinical evidence. Molecules 24(3):648
Article
CAS
PubMed Central
Google Scholar
Singh D, Hembrom S (2018) Neuroprotective effect of flavonoids: a systematic review. Int J Aging Res 2(1):1–17
CAS
Google Scholar
Ayaz M, Sadiq A, Junaid M, Ullah F, Ovais M, Ullah I, Ahmed J, Shahid M (2019) Flavonoids as prospective neuroprotectants and their therapeutic propensity in ageing-associated neurological disorders. Front Aging Neurosci 11:155–169
Article
CAS
PubMed
PubMed Central
Google Scholar
Hasan W, Kori RK, Jain J, Yadav RS, Jat D (2020) Neuroprotective effects of mitochondria-targeted curcumin against rotenone-induced oxidative damage in cerebellum of mice. J Biochem Mol Toxic 34(1):1–8
Article
CAS
Google Scholar
Cyr M, Calon F, Morissette M, Di Paolo T (2002) Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson’s disease. J Psychiatry Neurosci 27(1):12–27
PubMed
PubMed Central
Google Scholar
da Silva FC, de Oliveira Cito MD, da Silva MI, Moura BA, de Aquino Neto MR, Feitosa ML, de Castro CR, Macedo DS, de Vasconcelos SM, de França Fonteles MM, de Sousa FC (2010) Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice. Brain Res Bull 83(1–2):9–15
Article
PubMed
CAS
Google Scholar
Sharma K, Parle M, Yadav M (2016) Evaluation of antipsychotic effect of methanolic extract of Ocimum sanctum leaves on laboratory animals. J Appl Pharm Sci 6(5):171–177
Article
CAS
Google Scholar
Sharma AC, Kulkarni SK (1992) Evaluation of learning and memory mechanisms employing elevated plus-maze in rats and mice. Prog Neuropsychopharmacol Biol Psychiatry 16(1):117–125
Article
CAS
PubMed
Google Scholar
Chhillar R, Dhingra D (2013) Antidepressant-like activity of gallic acid in mice subjected to unpredictable chronic mild stress. Fund Clin Pharmacol 27(4):409–418
Article
CAS
Google Scholar
Yadav M, Jindal DK, Dhingra MS, Kumar A, Parle M, Dhingra S (2018) Protective effect of gallic acid in experimental model of ketamine-induced psychosis: possible behaviour, biochemical, neurochemical and cellular alterations. Inflammopharmacology 26(2):413–424
Article
CAS
PubMed
Google Scholar
Brown MR, Sullivan PG, Dorenbos KA, Modafferi EA, Geddes JW, Steward O (2004) Nitrogen disruption of synaptoneurosomes: an alternative method to isolate brain mitochondria. J Neurosci Methods 137(2):299–303
Article
CAS
PubMed
Google Scholar
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–225
Article
CAS
PubMed
Google Scholar
Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82(1):70–77
Article
CAS
PubMed
Google Scholar
Luck H (1971) Catalase in methods of enzymatic analysis (Bergmeyer HU Edn). Academic Press, New York, pp 885–893
Google Scholar
Kono Y (1978) Generation of superoxide radicals during auto-oxidation of hydroxyl-amine hydrochloride an assay for SOD. Arch Biochem Biophys 186(1):189–195
Article
CAS
PubMed
Google Scholar
King TE, Howard RL (1967) Preparations and properties of soluble NADH dehydrogenases from cardiac muscle. Methods Enzymol 10:275–294
Article
CAS
Google Scholar
King TE (1967) Preparation of succinate dehydrogenase and reconstitution of succinate oxidase. Methods Enzymol 10:322–331
Article
CAS
Google Scholar
Liu Y, Peterson DA, Kimura H, Schubert D (2002) Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem 69(2):581–593
Article
Google Scholar
Sottocasa GL, Kuylenstierna B, Ernster L, Bergstrand A (1967) An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study. J Cell Biol 32(20):415–438
Article
CAS
PubMed
PubMed Central
Google Scholar
Chatterjee M, Verma P, Maurya R, Palit G (2011) Evaluation of ethanol leaf extract of ocimum sanctum in experimental models of anxiety and depression. Pharm Biol 49(5):477–483
Article
PubMed
Google Scholar
Chatterjee M, Verma R, Ganguly S, Palit G (2012) Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice. Neuropharmacology 63(6):1161–1171
Article
CAS
PubMed
Google Scholar
Dajas F, Rivera-Megret A, Blasina F, Arrendondo F, Abin-Carriquiry JA, Costa G (2003) Neuroprotection by flavonoids. Braz J Med Biol Res 36(12):1613–1620
Article
CAS
PubMed
Google Scholar
Pietta PG (2000) Flavonoids as antioxidants. J Nat Prod 63(7):1035–1042
Article
CAS
PubMed
Google Scholar
Lagoa R, Graziani I, Lopez-Sanchez C, Garcia-Martinez V, Gutierrez-Merino C (2011) Complex I and cytochrome-C are molecular targets of flavonoids that inhibit hydrogen peroxide production by mitochondria. BBA-Bioenergetics 1807(12):1562–1572
Article
CAS
PubMed
Google Scholar
Hanrahan JR, Chebib M, Johnston GAR (2011) Flavonoid modulation of GABA-A receptors. Br J Pharmacol 163(2):234–245
Article
CAS
PubMed
PubMed Central
Google Scholar
Khan H, Perviz S, Sureda A, Nabavi SM, Tejada S (2018) Current standing of plant derived flavonoids as an antidepressant. Food Chem Toxicol 119:176–188
Article
CAS
PubMed
Google Scholar
Spencer JPE (2013) Flavonoids: modulators of brain function? Brit J Nutr 99(E-S1):60–77
Article
Google Scholar
Spencer JPE (2014) The impact of flavonoids on memory: physiological and molecular considerations. Chem Soc Rev 38(4):1152–1161
Article
CAS
Google Scholar
Vauzour D (2014) Effect of flavonoids on learning, memory and neurocognitive performance: relevance and potential implications for Alzheimer’s disease pathophysiology. J Sci Food Agric 94(6):1042–1056
Article
CAS
PubMed
Google Scholar
Barron H, Hafizi S, Andreazza AC, Mizrahi R (2017) Neuroinflammation and oxidative stress in psychosis and psychosis risk. Int J Mol Sci 18(3):651–664
Article
PubMed Central
CAS
Google Scholar
Grima G, Benz B, Parpura V, Cuenod M, Do KQ (2003) Dopamine-induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia. Schizophr Res 62(3):213–224
Article
PubMed
Google Scholar
Sorce S, Schiavone S, Tucci P, Colaianna M, Jaquet V, Cuomo V (2010) The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses. J Neurosci 30(34):11317–11325
Article
CAS
PubMed
PubMed Central
Google Scholar
Fraguas D, Díaz-Caneja CM, Rodríguez-Quiroga A, Arango C (2017) Oxidative stress and inflammation in early onset first episode psychosis: a systematic review and meta-analysis. Int J Neuropsychoph 20(5):435–444
Article
CAS
Google Scholar
Varga V, Jenaei Z, Janáky R, Saransaari P, Oja SS (1997) Glutathione is an endogenous ligand of rat brain N-methyl-d-aspartate (NMDA) and 2-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors. Neurochem Res 22(9):1165–1171
Article
CAS
PubMed
Google Scholar
Wallin C, Weber SG, Sandberg M (1998) Glutathione efflux induced by NMDA and kainate: implications in neurotoxicity? J Neurochem 73(4):1566–1572
Article
Google Scholar
Dean O, den Buuse M, Bush AI, Copolov DL, Ng F, Dodd S, Berk M (2009) A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice. Curr Med Chem 16(23):2965–2976
Article
CAS
PubMed
Google Scholar
Nucifora LG, Tanaka T, Hayes LN, Kim M, Lee BJ, Matsuda T (2017) Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry. Transl Psychiatry 7(8):e1215
Article
CAS
PubMed
PubMed Central
Google Scholar
Hussain S, Slikker W, Ali SF (1995) Age-related changes in antioxidant enzymes, superoxide dismutase, catalase, glutathione peroxidase and glutathione in different regions of mouse brain. Int J Dev Neurosci 13(8):811–817
Article
CAS
PubMed
Google Scholar
Conus P, Fournier M, Xin L, Baumann P, Ferrari C, Cousins A et al (2017) N-acetyl-cysteine in a double-blind randomized placebo-controlled trial: towards biomarker-guided treatment in early psychosis. Eur Psychiatry 44(2):s806–s806
Article
Google Scholar
Schiavone S, Trabace L (2018) The use of antioxidant compounds in the treatment of first psychotic episode: highlights from preclinical studies. CNS Neurosci Ther 24(6):465–472
Article
PubMed
PubMed Central
Google Scholar
Keller JN, Kindy MS, Holtsberg FW, St. Clair DK, Yen HC, Germeyer A et al (1998) Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci 18(2):687–697
Article
CAS
PubMed
PubMed Central
Google Scholar
Martínez-Cengotitabengoa M, Mac-Dowell KS, Leza JC, Mico JA, Fernandez M, Echevarría E, Sanjuan J, Julian E, Gonzalez-Pinto A (2012) Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes. Schizophr Res 137(1–3):66–72
Article
PubMed
Google Scholar
Evans DR, Parikh VV, Khan MM, Coussons C, Buckley PF, Mahadik SP (2003) Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. Prostag Leukotr Ess 69(6):393–399
Article
CAS
Google Scholar
Acin-Perez R, Salazar E, Kamenetsky M, Buck J, Levin LR, Manfredi G (2009) Cyclic AMP produced inside mitochondria regulates oxidative phosphorylation. Cell Metab 9(3):265–276
Article
CAS
PubMed
PubMed Central
Google Scholar
Seth RB, Sun L, Ea CK, Chen ZJ (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3. Cell 122(5):669–682
Article
CAS
PubMed
Google Scholar
Ricci JE, Munoz-Pinedo C, Fitzgerald P, Bailly-Maitre B, Perkins GA, Yadava N (2004) Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell 117(6):773–786
Article
CAS
PubMed
Google Scholar
Valsecchi F, Ramos-Espiritu LS, Buck J, Levin LR, Manfredi G (2009) cAMP and mitochondria. Physiology 28(3):199–209
Article
CAS
Google Scholar
Wallace DC (1999) Mitochondrial diseases in man and mouse. Science 283(5407):1482–1488
Article
CAS
PubMed
Google Scholar
Fattal O, Budur K, Vaughan AJ, Franco K (2006) Review of the literature on major mental disorders in adult patients with mitochondrial diseases. Psychosomatics 47(1):1–7
Article
PubMed
Google Scholar
De Oliveira L, Fraga DB, De Luca RD, Canever L, Ghedim FV, Matos MP, Streck EL, Quevedo J, Zugno AI (2011) Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine. Metab Brain Dis 26(1):69–77
Article
PubMed
CAS
Google Scholar
Robinson BL, Dumas M, Ali SF, Paule MG, Gu Q, Kanungo J (2018) Mechanistic studies on ketamine-induced mitochondrial toxicity in zebrafish embryos. Neurotoxicol Teratol 69:63–72
Article
CAS
PubMed
Google Scholar
Takada M, Ikenoya S, Yuzuriha T, Katayama K (1982) Studies on reduced and oxidized coenzyme Q (ubiquinones) II. The determination of oxidation-reduction levels of coenzyme Q in mitochondria, microsomes and plasma by high-performance liquid chromatography. BBA-Bioenergetics 679(2):308–314
Article
CAS
PubMed
Google Scholar
Monsef A, Shahidi S, Komaki A (2019) Influence of chronic coenzyme Q10 supplementation on cognitive function, learning and memory in healthy and diabetic middle-aged rats. Neuropsychobiology 77(2):92–100
Article
PubMed
CAS
Google Scholar
Hüttemann M, Helling S, Sanderson TH, Sinkler C, Samavati L, Mahapatra G et al (2012) Regulation of mitochondrial respiration and apoptosis through cell signaling: cytochrome c oxidase and cytochrome c in ischemia/reperfusion injury and inflammation. BBA-Bioenergetics 1817(4):598–609
Article
PubMed
CAS
Google Scholar